Calgary’s Ocumetics announced today that their intraocular lenses are now being manufactured for the upcoming first-in-human study in the Dominican Republic.
Ocumetics Lens technologies have been designed to create an accommodating intraocular lens, which fits within the lens capsule and eliminates the need for corrective lenses, using the natural kinetics in the eye ciliary muscles and zonules.
The proprietary design has been created to be used as a replaceable device that serves secondarily as a docking station for customized optics and evolving nanotechnologies.
“We are thrilled to collaborate with Bioana, leveraging their medical device expertise and cutting-edge manufacturing facilities to bring our innovative intraocular lenses to life,” said Dean Burns, CEO of Ocumetics. “Producing these lenses is a critical milestone in our mission to provide clear distance and near vision after cataract surgery.”
The Ocumetics lenses promise groundbreaking enhancements to vision correction technology. Designed to provide excellent visual acuity at all distances and improved quality of life for patients, these lenses are set to be evaluated in an upcoming first-in-human clinical study in the Dominican Republic.
Bioana’s state-of-the-art design expertise, manufacturing capabilities and commitment to excellence align perfectly with Ocumetics’ dedication to developing top-tier accommodating intraocular lenses. The initial production run will support the clinical evaluation process, providing essential data to ensure the safety and efficacy of the Ocumetics lens.
“We are honored to be selected by Ocumetics for this pivotal project,” said Adriana Torres COO and Chief Engineer at Bioana, a premier design and development firm in Monterrey, Mexico. “Our team is excited to apply our extensive experience in medical device manufacturing to help Ocumetics achieve their vision of transforming eye care.”
The first-in-human study in the Dominican Republic is a crucial step toward bringing these innovative lenses to market. The study will evaluate the performance of the Ocumetics lenses in a clinical setting, providing valuable data, as Ocumetics works to obtain regulatory clearance for its accommodating intraocular lenses.
Leave a Reply